| Gene Name |
Pubmed ID |
Classification |
Sample Location |
Remark |
| CCND1 | 17306351 | Overexpression | Clinic of Obstetrics and Gynaecology at the Medical University of Vienna, Austria. | It's increased 8.08 fold level in HR-HPV(-) cervical squamous cell carcinoma than HR-HPV(+) squamous cell carcinoma. |
| CCND1 | 15771902 | Overexpression | - | CCND1 protoncogene showed a 8.08 fold higher increase in malignant cervical squamous cells |
| CCND1 | 7905784 | Amplification | Lok Nayak Jayaprakashan Naryan Hospital, Delhi, India. | CCND1 has been shown to be amplified with with 18 number of copies in cervical cancer. |
| CCND1 | 7812927 | Overexpression | - | The role of PRAD1 as a cell cycle regulatory gene and its interaction with the Rb Tumor suppressor gene suggests that PRAD1 deregulation may be a significant molecular event in the evolution of these tumors. |
| CCND1 | 7905784 | Amplification | Lok Nayak Jayaprakashan Naryan Hospital, Delhi, India. | BCL1 has been shown to be amplified with 5 number of copies in cervical cancer. |
| CCND1 | 18813814 | Upregulation | Department of Obsterics and Gynaecology of the University Hospital of Heraklion, Crete | This gene is found to be upregulated 77% and 52% in cervical carcinoma and HSIL cases. |